• Users Online: 18
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 


 
   Table of Contents      
ORIGINAL ARTICLE
Year : 2015  |  Volume : 13  |  Issue : 1  |  Page : 21-25

Assessment of level of adherence to antiretroviral therapy among human immune deficiency virus/acquired immune deficiency syndrome patients at Imo State University Teaching Hospital, Orlu, Nigeria


1 Department of Family Medicine, Imo State University Teaching Hospital, Orlu, Nigeria
2 Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnamdi Azikiwe University, Nnewi, Nigeria
3 Department of Community Medicine, Imo State University Teaching Hospital, Orlu, Nigeria

Date of Web Publication12-Jun-2015

Correspondence Address:
Prosper O.U. Adogu
Department of Community Medicine, Nnamdi Azikiwe University Teaching Hospital, Nnamdi Azikiwe University, Nnewi
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1118-4647.158709

Rights and Permissions
  Abstract 

Background: Antiretroviral therapy (ART) is not a cure for human immune deficiency virus/acquired immune deficiency syndrome (HIV/AIDS), but rather it is used for optimal suppression of the viral load to an undetectable serum level, hence it remains a palliative measure to improve the quality of life and longevity by impeding the rate of disease progression. Objective: The objective was to evaluate the level of adherence, the prevailing contributory factors to adherence as well as nonadherence of HIV/AIDS patients to ART at Imo State University Teaching Hospital (IMSUTH), Orlu, Nigeria. Methodology: A descriptive cross-sectional study of HIV/AIDS patients receiving anti-retroviral drugs at IMSUTH, Orlu. It was carried out using interviewer - administered questionnaire involving 400 respondents. The collected data was analyzed manually using electronic calculator and results were presented in frequency tables. Results: The result showed a high level of adherence of HIV/AIDS patients to anti-retroviral drugs as 383 (96.2%) were adherent, while 15 (3.8%) were not adherent. Some reasons given for nonadherence to treatment were self-discouragement, toxicity of the drugs especially skin rashes, attitude of health workers, stigma, and distance to the hospital hence they may not be able to access their medications as and at when due. Conclusion: There is a significant high level of adherence of HIV/AIDS patients to ART at IMSUTH, Orlu, probably due to their high level of formal education as majority of the respondents 333 (83.0%) achieved at least a secondary level of education.

Keywords: Adherence, antiretroviral therapy, assessment, human immune deficiency virus/acquired immune deficiency syndrome, Imo State University Teaching Hospital


How to cite this article:
Chineke H N, Adogu PO, Uwakwe K A, Ewuzie M U. Assessment of level of adherence to antiretroviral therapy among human immune deficiency virus/acquired immune deficiency syndrome patients at Imo State University Teaching Hospital, Orlu, Nigeria. Niger J Gen Pract 2015;13:21-5

How to cite this URL:
Chineke H N, Adogu PO, Uwakwe K A, Ewuzie M U. Assessment of level of adherence to antiretroviral therapy among human immune deficiency virus/acquired immune deficiency syndrome patients at Imo State University Teaching Hospital, Orlu, Nigeria. Niger J Gen Pract [serial online] 2015 [cited 2019 Dec 15];13:21-5. Available from: http://www.njgp.org/text.asp?2015/13/1/21/158709


  Introduction Top


Antiretroviral therapy (ART) is not a cure for human immune deficiency virus/acquired immune deficiency syndrome (HIV/AIDS), but is rather used for optimal suppression of the viral load to an undetectable level. [1] Many studies have also documented that combination of antiretroviral drugs can inhibit replication, thus leading to a significant decline in HIV associated mortality. [2]

Appropriate use of ART has improved the health of many HIV positive individuals, who otherwise would have died. It should be noted however that the efficiency of any treatment depends on sustained high levels of adherence to ART. [3] ART, at present, is a lifelong treatment and its effectiveness depends critically on both the therapeutic efficacy of the antiretroviral drugs and high level of adherence (>95%) to the medications. [4],[5]

A patient's ability and willingness to follow a prescribed regimen directly influences the effectiveness of that therapy. In general, the factors that influence adherence to ART are categorized into (a) Patient-related factors (psychosocial and educational) (b) patient-provider factors (interaction with physicians and other health workers and access to medications), and (c) clinical factors (pill burden, dosing frequency and adverse effects of medications, duration of medications, presence of comorbidity, etc). [6]

Medication adherence is the term used to describe the patient's behavior of taking drugs correctly, the right drug in the right dose, with the right frequency, and at the right time. [7],[8] Adherence to ART is defined as the ability of the HIV infected patient to be involved in choosing, starting, managing a given therapeutic combination medication recognized to control HIV replication and improve immune functions. It involves a partnership between the patient and the health care team. [9]

Nonadherence is the term used to describe the patient's inability to take their drugs in the prescribed manner. Factors contributing to it are patient-related factors, provider related, disease-related, and environmental-related factors. [9] Various methods exist for the assessment of drug adherence in a clinical setting. There is however, complicating evidence on which measures generate the best estimate of a patient's drugs adherence level. As a result, there may not be a gold standard for the assessment of level of adherence. [10]

Methods used in clinical practice are typically simple assessments of medication refill history or a patient-recall assessment. [11] These methods are easy to perform; however, they are cruder and their accuracy is limited. Although some suggest that the patient-recall and refill history assessments are accurate enough, especially when performed in combination, [11] these methods are generally regarded to substantially overestimate medication adherence. [11] In addition, the ability of the patient-recall and refill history to detect changes in adherence is unknown. In comparison, pill counts are laborious and rely upon the assumption that medications missing from the pill bottle were taken. [11] They also rely upon accurate reporting dates for starting prescriptions but can be more precise when carefully performed. This study adopted the use of patient-recall assessment (through patient questionnaires) to determine the level of adherence to ART among the respondents.

Adherence to ART has been strongly correlated with HIV viral suppression, reduced rate of resistance, an increase in survival rate and an improved quality of life. [12] Efforts to maximize the patient's adherence will be crucial to the prevention of the emergence of drug - resistant virus strains. [9]

This study is aimed at evaluating the level of adherence, the prevailing contributory factors to adherence as well is nonadherence of HIV/AIDS patients to ART at Imo State University Teaching Hospital (IMSUTH), Orlu, Nigeria.


  Methodology Top


Study area

It was conducted in IMSUTH, Orlu, South East Nigeria. Orlu is located at the intersection of latitude 5°48' North and longitude 7°0' East. The hospital provides Tertiary Health Care services as well as being a training center for both undergraduate and post graduate medical and allied health sciences programs. Its catchment areas include the surrounding states such as Anambra, Rivers, Abia, Delta, and Enugu.

Study population

It included all the HIV/AIDS patients receiving antiretroviral treatment at IMSUTH, Orlu, irrespective of age, gender and parity.

Study design

A descriptive cross-sectional study of HIV positive patients receiving antiretroviral drugs at IMSUTH, Orlu. The study instrument used was interviewer - administered questionnaire containing both open-ended and closed-ended questions that were distributed to the respondents.

The questions covered include: Sociodemographic data of respondents, knowledge of ART, service reviewed among others.

Inclusion and exclusion criteria

Inclusion criteria


This includes all HIV positive patients attending ART clinics in IMSUTH, Orlu during the study period.

Exclusion criteria

Non-HIV positive patients in IMSUTH, Orlu.

Sample size calculation

The minimum sample size for the target population desired for this study was calculated using this formula:



To take care of nonresponse and attrition 10% of the above calculated minimum sample size was added to it to give a study sample of 381.

However, for the purpose of this work, a sample size of 400 was used.

Data collection, analysis and presentation

Data was collected from the respondents using interviewer-administered questionnaires and information sourced from their medical records. The question on the questionnaire was grouped into six subsections via:

Section A: Sociodemographic data; Section B: Knowledge of HIV/AIDS and ART; Section C: Level of adherence to ART; Section D: The most common cause of nonadherence; Section E: Relationship between nonadherence/adherence and formal education; Section F: The male - female ratio to level of adherence.

The collected data were manually analyzed with an electronic calculator and results presented in frequency tables.

Ethical considerations

Written consent for the study was obtained from the Research and Ethics Committee of IMSUTH, Orlu prior to the commencements. Furthermore, verbal consents were obtained from the respondents with the assurance of confidentiality given.


  Results Top


Following a cross-sectional survey of 400 patients in the study site, the result obtained is itemized below, with tables.

[Table 1] shows that respondents were predominantly between the ages of 21-55 years; 300 (75%) while 5 (1.3%) were below the age of 12 years. Majority of the respondents were females 264 (66%) while 136 (34%) were males. Two hundred and seventeen (54.3%) of the respondents are senior secondary certificate examination holders while 116 (29%) are First School Leaving Certificate holders. Two hundred (50%) of the respondents earn 1-10,000 naira per month while 20 (5%) earn more than 100,000. Two hundred and fifteen (53.8%) of the respondents are married while 118 (29.5%) are single. Furthermore, majority 147 (36.8%) of the respondents are traders while farmers were least in number (not shown in table).
Table 1: Sociodemographic variables of respondents


Click here to view


[Table 2] indicates that 396 (99%) are aware of the HIV virus while 4 (1%) were ignorant of the virus. Majority 358 (40.5%) are knowledgeable that the virus is contacted through sexual intercourse while 100 (11.3%) know that it can be transmitted from mother to child.
Table 2: Respondents' awareness/knowledge of HIV


Click here to view


In [Table 3], 72 (52.6%) of the male respondents were adherent to ART, while 147 (56.3%) female respondents were adherent giving a total adherence of 219 (54.8%) meaning that nonadherence was 181 (45.2%). The difference in adherence between the male and female respondents is however not statistically significant (P > 0.5).
Table 3: Respondents' adherence to therapy


Click here to view


[Table 4] shows that self-discouragement for being infected with HIV/AIDS 137 (34.2%) was the most common reason for nonadherence followed by ARV being out of stock at the hospital 88 (22.0%).
Table 4: Major reason for nonadherence to therapy


Click here to view



  Discussion Top


Adherence is the "active, voluntary, and collaborative involvement of the patient in a mutually acceptable course of behavior to produce a therapeutic result". [13] Strict adherence to ART is key to sustained HIV suppression, reduced risk of drug resistance, improved overall health, quality of life, and survival, [14],[15],[16] as well as decreased risk of HIV transmission [16] This study shows that there is a high level of awareness of both HIV/AIDS and ART among the respondents. There was also a fairly high level of adherence to ART by the respondents. The level of nonadherence, on the other hand was high 181 (45.2%) but not as high as that reported by Golin et al., [17] who had a 75% level of nonadherence in their study. It was also at variance with the findings of Walsh et al., [18] who obtained a high level of 95% adherence and only 5% nonadherence. Adherence to ART can be influenced by a number of factors, including the patient's social situation and clinical condition; the prescribed regimen; and the patient-provider relationship. [19] It is critical that each patient receives and understands information about HIV disease including the goals of therapy (achieving and maintaining viral suppression, decreasing HIV-associated morbidity and mortality, and preventing sexual transmission of HIV), the prescribed regimen (including dosing schedule and potential side effects), the importance of strict adherence to ART, and the potential for the development of drug resistance as a consequence of suboptimal adherence. However, information alone is not sufficient to assure high levels of adherence; patients must also be positively motivated to initiate and maintain therapy. [20]

The most common cause of nonadherence was respondent based rather than hospital based; this was also similar to the findings of Golin et al. [17] The reasons for poor medication adherence are often multifactorial. Nonadherence to medications can be intentional or nonintentional. Intentional nonadherence is an active process whereby the patient chooses to deviate from the treatment regimen. [21] This may be a rational decision process in which the individual weighs the risk and benefits of treatment against any adverse effects. Unintentional nonadherence is a passive process in which the patient may be careless or forgetful about adhering to the treatment regimen. Most deviations in medication taking are due to omissions of doses or delays in taking doses. In addition, it is common for patients to improve their medication-taking behavior shortly before and after an appointment with a healthcare provider. [22]

On the other hand, the moderately high level of adherence among responds in this study may be attributed to their high level of education as they can easily access health information from the internet using modern technology. This finding was similar to that of Mariya et al., [23] in Kano, North Western Nigeria. The moderately high level of adherence in this study may also be explained from the point of view of female gender preponderance, in which females constituted 66% of the respondents and given that more females than males adhered to their ART, even though the difference was not statistically significant. Nevertheless, it is known that females are much more self-caring and less occupied with other activities than males who may easily forget their drugs. [24]

Our finding however was in contrast to that of Hogg et al., [25] in which females had a very low level of adherence to antiretroviral drugs due to higher frequency of side effects like urticaria, lactic acidosis, dyslipidemia, liver toxicity, etc., Our finding was also different to that of the United Nations AIDS 2008 report on the global AIDS pandemic in which low adherence was observed in females due to preponderance of side effects on them. [26]

This study also suggests that the socioeconomic status of the patient had little or no effect on the level of adherence since the drug is being supplied free of charge. However, low socioeconomic status may raise mortality rate from HIV/AIDS as reported by Palella et al. [27] It was observed during the review of folders that many of the patients have been on treatment for over 5 years with a normal lifestyle and an increasing CD4 count. It is therefore only natural to assume that the moderate level of adherence has contributed greatly in reducing the level of progression of HIV to AIDS in our study population. This agreed with the finding of Bangsbery et al., [28] who asserted that reduction in level of progression made the patients feel stronger, happier, and healthier.


  Conclusion Top


The level of adherence of patients to ART in IMSUTH, Orlu is moderately high and could be linked to the high level of awareness of ART and HIV/AIDS also shown by respondents in the study population. Nevertheless, the nonadherence rate is equally high and slightly more among the males than females.

Some of the causes of nonadherence were self-discouragement by many of the respondents on account of their HIV/AIDS status, out of stock syndrome of ART at various treatment centers, side effect of drugs, attitude of health workers, stigmata, etc.


  Recommendations Top


Although research is continuing to enable us to better understand medication adherence, there is an urgent need to improve current rates of nonadherence. One of the first steps is a broader recognition of the problem of medication nonadherence, given that it is frequently unrecognized. The government should ensure regular supply of antiretroviral to ensure continuity of treatment while patients should be positively motivated and encouraged by caretakers to initiate and continue with their treatment and not to despair on account of their status.

 
  References Top

1.
Nagot N, Ouedraogo A, Weiss HA, Konate I, Sanon A, Defer MC, et al. Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso. Sex Transm Infect 2008;84:167-70.  Back to cited text no. 1
    
2.
Lalani T, Hicks C. Does antiretroviral therapy prevent HIV transmission to sexual partners? Curr Infect Dis Rep 2008;10:140-5.  Back to cited text no. 2
    
3.
Castilla J, Del Romero J, Hernando V, Marincovich B, García S, Rodríguez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr 2005;40:96-101.  Back to cited text no. 3
    
4.
Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, Neaton JD, Gordin F, Abrams D, et al. CD4 count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355:2283-96.  Back to cited text no. 4
    
5.
Ruiz L, Paredes R, Gómez G, Romeu J, Domingo P, Pérez-Alvarez N, et al. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients. AIDS 2007;21:169-78.  Back to cited text no. 5
    
6.
Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr 2003;34:281-8.  Back to cited text no. 6
    
7.
Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev 2007;15:257-63.  Back to cited text no. 7
    
8.
Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006;19:1190-6.  Back to cited text no. 8
    
9.
Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: A review of literature. J Behav Med 2008;31:213-24.  Back to cited text no. 9
    
10.
Lucas GM, Wu AW, Cheever LW. Adherence to antiretroviral therapy: an update of current concepts. Curr HIV/AIDS Rep 2004;1:172-80.  Back to cited text no. 10
    
11.
Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ, et al. How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag 2007;3:685-90.  Back to cited text no. 11
    
12.
Valenti WM. Treatment adherence improves outcomes and manages costs. AIDS Read 2001;11:77-80.  Back to cited text no. 12
    
13.
Delamater AM. Improving patient adherence. Clin Diabetes 2006;24:71-7.  Back to cited text no. 13
    
14.
Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr 2006;43 Suppl 1:S149-55.  Back to cited text no. 14
    
15.
World Heath Organization (WHO). Adherence to Long Term Therapies - Evidence for Action; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. [Last accessed on 2015 Feb 12].  Back to cited text no. 15
    
16.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.  Back to cited text no. 16
    
17.
Golin CE, Liu H, Hays RD. A prospective study of predictors of adherence to combination antiretroviral medication. Gen Intern Med 2002;133:21-30.  Back to cited text no. 17
    
18.
Walsh JC, Madalia S, Gizzard BG. Responses to a month self report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. J Int AIDS Soc 2002;18:269-77.  Back to cited text no. 18
    
19.
Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 2004;19:1096-103.  Back to cited text no. 19
    
20.
Halkitis PN, Shrem MT, Zade DD, Wilton L. The physical, emotional and interpersonal impact of HAART: Exploring the realities of HIV seropositive individuals on combination therapy. J Health Psychol 2005;10:345-58.  Back to cited text no. 20
    
21.
Lowry KP, Dudley TK, Oddone EZ, Bosworth HB. Intentional and unintentional nonadherence to antihypertensive medication. Ann Pharmacother 2005;39:1198-203.  Back to cited text no. 21
    
22.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.  Back to cited text no. 22
    
23.
Mukhtar-Yola M, Adeleke S, Gwarzo D, Ladan ZF. Preliminary investigation of adherence to antiretroviral therapy among children in Aminu Kano Teaching Hospital, Nigeria. Afr J AIDS Res 2006;5:141-4.  Back to cited text no. 23
    
24.
Streisand R, Respess D, Overstreet S, Gonzalez de Pijem L, Chen RS, Holmes C. Brief report: Self-care behaviors of children with type 1 diabetes living in Puerto Rico. J Pediatr Psychol 2002;27:759-64.  Back to cited text no. 24
    
25.
Hogg R, Tip B, Chan K, O'Shaughnessy M, Montener J. Non Adherence to Triple Combination Antiretroviral Therapy is Predictive of AIDS Progression and Death in HIV Positive Men and Women. International Conference AIDS; 9-14 July, 2000. p. 13. [Abstract no. Jour B 419].  Back to cited text no. 25
    
26.
UNAIDS. 2008 Report on the Global AIDS Epidemic. Geneva: UNAIDS; 2008.  Back to cited text no. 26
    
27.
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.  Back to cited text no. 27
    
28.
Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-3.  Back to cited text no. 28
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Introduction
Methodology
Results
Discussion
Conclusion
Recommendations
References
Article Tables

 Article Access Statistics
    Viewed2586    
    Printed244    
    Emailed0    
    PDF Downloaded288    
    Comments [Add]    

Recommend this journal